Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Researchers used a SARS-CoV-2 spike protein-pseudotyped viral model to characterize BA.2.86 variant neutralization by monoclonal antibodies.

Research opens up new directions to develop drugs for stopping cytokine storms

Constant exposure of cells to stressing agents, such as pathogens, may disturb an organism’s normal functioning. To fight stress, cells have developed several coping mechanisms,

September 14, 2023

Oracle Health chair says Cerner isn’t competing with Epic

Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems, but new owner Oracle plans to close the gap with

March 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Researchers characterize new SARS-CoV-2 BA.2.86 variant neutralization by monoclonal antibodies

Research opens up new directions to develop drugs for stopping cytokine storms

Oracle Health chair says Cerner isn’t competing with Epic

Novel replacement strategy holds promise for the treatment of various genetic disorders

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe